Phase II study of single agent clofarabine in previously untreated older adult patients with acute myelogenous leukemia (AML) unlikely to benefit from standard induction chemotherapy
2008 ◽
Vol 26
(15_suppl)
◽
pp. 7025-7025
◽
Keyword(s):
Phase Ii
◽